toplogo
Accedi

Detection of Subclinical Atherosclerosis by Image-Based Deep Learning on Chest X-Ray


Concetti Chiave
The AI-CAC model accurately detects subclinical atherosclerosis on chest x-ray with elevated sensitivity and predicts ASCVD events with high negative predictive value.
Sintesi
The study developed a deep-learning AI-CAC model for subclinical atherosclerosis detection on chest x-rays. The model was trained and validated on patient cohorts, showing high sensitivity and specificity. AI-CAC accurately predicted CAC >0 with AUC of 0.90 in internal validation and 0.77 in external validation. The model's prognostic value was demonstrated by predicting ASCVD events independently of CV risk grading. AI-CAC may refine CV risk stratification and serve as an opportunistic screening tool.
Statistiche
The AI-CAC model had an AUC of 0.90 in the internal validation cohort. Sensitivity was consistently above 92% in both cohorts. Among patients with AI-CAC=0, a single ASCVD event occurred after 4.3 years.
Citazioni
"The AI-CAC model accurately detects subclinical atherosclerosis on chest x-ray." "Patients with AI-CAC>0 had significantly higher Kaplan Meier estimates for ASCVD events."

Domande più approfondite

How can the AI-CAC model impact primary prevention strategies?

The AI-CAC model can have a significant impact on primary prevention strategies by providing a more accurate and efficient way to detect subclinical atherosclerosis. This model, based on deep learning algorithms, can accurately predict coronary artery calcium (CAC) scores on chest x-rays. By identifying individuals with subclinical atherosclerosis, the AI-CAC model can help healthcare providers tailor preventive measures more effectively. This can lead to early intervention and targeted treatments for individuals at higher risk of cardiovascular events, ultimately improving outcomes and reducing the burden of cardiovascular disease.

What are the potential limitations of using AI-CAC for CV risk stratification?

While the AI-CAC model shows promise in detecting subclinical atherosclerosis, there are several potential limitations to consider when using it for cardiovascular (CV) risk stratification. Limited Generalizability: The model's performance may vary when applied to different populations or settings, impacting its generalizability. Data Quality: The accuracy of the AI-CAC model is highly dependent on the quality of the input data, including the chest x-ray images and the ground truth CAC scores from CT scans. Interpretability: Deep learning models like AI-CAC can be complex and challenging to interpret, making it difficult to understand how the model arrives at its predictions. Validation: The model needs rigorous validation in diverse populations to ensure its accuracy and reliability in real-world clinical settings. Ethical Considerations: There may be ethical concerns related to data privacy, bias in the model, and the potential impact on patient care and decision-making.

How might the explainability of the AI-CAC model influence its clinical adoption?

The explainability of the AI-CAC model is crucial for its clinical adoption and acceptance by healthcare providers. By providing insights into how the model makes its predictions, explainability enhances transparency and trust in the model's decision-making process. Clinical Decision Support: Explainable AI can help clinicians understand the rationale behind the model's recommendations, enabling them to make more informed decisions. Risk Communication: Clear explanations of the model's predictions can facilitate effective communication with patients about their cardiovascular risk, treatment options, and preventive measures. Regulatory Compliance: Explainability is essential for regulatory compliance and ensuring that the model meets the necessary standards for clinical use. Quality Improvement: Understanding how the model works can help identify areas for improvement, refine the model's performance, and enhance its clinical utility. In summary, explainability plays a vital role in the adoption of the AI-CAC model in clinical practice, promoting trust, understanding, and effective utilization of the model for CV risk stratification.
0
visual_icon
generate_icon
translate_icon
scholar_search_icon
star